Becton Dickinson and Co (NYSE:BDX) to Present at Sanford C Bernstein & Co Strategic Decisions Conference May 28

Becton Dickinson and Co (NYSE:BDX) will speak at the Sanford C. Bernstein & Co Strategic Decisions Conference in New York City, New York on Wednesday, May 28 at 8:00 am.  A live webcast of the presentation will be made available at bd.com/investors on the Events page. 

Becton, Dickinson and Company (BD), is a medical technology company engaged in the manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

The segments in which the Company operates include BD Medical, BD Diagnostics and BD Biosciences. As of December 20, 2006, BD acquired the outstanding shares (approximately 93.8%) of TriPath Imaging, Inc. (TriPath). As of May 4, 2007, BD acquired all of the outstanding shares of Plasso Technology, Ltd. (Plasso). BD’s operations outside the United States are conducted in Canada, Japan, Asia Pacific, South Latin America and North Latin America.

Find more Conference Calls on Finditt Events.